Tuesday, August 18, 2020

Harmony Biosciences Announces Pricing Of Upsized Initial Public Offering

PLYMOUTH MEETING, Pa. and CHICAGO, Aug. 18, 2020 /PRNewswire/ -- Harmony Biosciences Holdings, Inc., a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients living with rare neurological disorders who have unmet medical needs, announced today...



from PR Newswire: https://ift.tt/3aETRDa

No comments:

Post a Comment